Related content

Luteolysis induced by a gonadotropin-releasing hormone agonist is the key to prevention of ovarian hyperstimulation syndrome

By Kol S.  

Fertility and Sterility, Vol. 81, Iss. 1, 2004-01 ,pp. : 1-5

Elsevier

Access to resources Recommend Favorite

Two rare events in one patient undergoing assisted conception: empty follicle syndrome and ovarian hyperstimulation with the sole administration of a gonadotropin-releasing hormone agonist - low-dose side effects in women and monkeys

By Khalaf Y.   Anderson H.   Taylor A.   Braude P.  

Fertility and Sterility, Vol. 73, Iss. 1, 2000-01 ,pp. : 171-172

Elsevier

Access to resources Recommend Favorite

Is coasting effective for preventing ovarian hyperstimulation syndrome in patients receiving a gonadotropin-releasing hormone antagonist during an in vitro fertilization cycle?

By Delvigne A.   Carlier C.   Rozenberg S.  

Fertility and Sterility, Vol. 76, Iss. 4, 2001-10 ,pp. : 844-846

Elsevier

Access to resources Recommend Favorite

Long-term remission of ovarian hyperandrogenism after short-term treatment with a gonadotropin-releasing hormone agonist

By Efstathiadou Z.   Tsatsoulis A.  

Fertility and Sterility, Vol. 75, Iss. 1, 2001-01 ,pp. : 59-62

Elsevier

Access to resources Recommend Favorite

A randomized controlled study comparing the endocrine effects of pulsatile intravenous gonadotropin-releasing hormone after gonadotropin-releasing hormone agonist pretreatment versus clomiphene citrate in patients with polycystic ovary syndrome

By Timmerman-van Kessel E.C.M.   Cikot R.J.L.M.   Dargel-Donkers E.J.H.   Zwertbroek W.   van Dop P.A.   Schoot D.C.  

Fertility and Sterility, Vol. 73, Iss. 6, 2000-06 ,pp. : 1145-1148

Elsevier

Access to resources Recommend Favorite